Cover Image

Emapalumab for Maladaptive Interferon‐γ‐Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First‐Line Antituberculosis Therapy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yahya Almodallal, Daniel Whitehurst, Sing Sing Way, Jane Koo, Ashish R. Kumar
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pediatric Blood & Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors
by: Aaron B. Ross, et al.
Published: (2025)

Desmoid‐Type Fibromatosis Tumors in Children After First‐Line Failure: Clinical Aspects and Approaches for Subsequent Therapeutic Lines
by: Anna Borovkov, et al.
Published: (2025)

Isolated Dermal Arteriolar Thrombosis in a Pediatric Patient: A Rare Complication During Eltrombopag Therapy for Chronic Immune Thrombocytopenia
by: Takashi Fujita, et al.
Published: (2026)

First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia
by: Nicolò Peccatori, et al.
Published: (2025)

Palliative care and suicidality: Complicated conversations at two ends of the spectrum
by: Maryland Pao, et al.
Published: (2024)

Complications at Diagnosis of Pediatric Chronic Myeloid Leukemia in Chronic Phase
by: Nirmalya Roy Moulik, et al.
Published: (2025)

Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma
by: Aseel Bzour, et al.
Published: (2025)

Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell Disease
by: Zachary Abramson, et al.
Published: (2025)

Leukoencephalopathy, a Frequent Complication After High‐Dose Methotrexate in Treatment of Osteosarcoma
by: Sandra Raimbault, et al.
Published: (2025)

Analysis of Late Complications Associated With Hematopoietic Stem Cell Transplantation in Patients With Dyskeratosis Congenita
by: Takashi Koike, et al.
Published: (2025)

Genomics of Long‐Term Complications of Childhood Leukemia: Rationale and Design of the GenLEA Study
by: Mathilde Veneziano‐Broccia, et al.
Published: (2026)

Evaluation of Pediatric and Young Adult Cancer Survivors at Risk of Long‐Term Kidney Complications
by: Ahmed Zeid, et al.
Published: (2025)

Association of Food Insecurity With Disease‐Related Complications and Healthcare Utilization for Patients With Sickle Cell Disease
by: Sharjeel Syed, et al.
Published: (2025)

Utility of Computed Tomography Surveillance of Asymptomatic Infection in Children and Young Adults Before Allogeneic Hematopoietic Stem Cell Transplant
by: Tyler Obermark, et al.
Published: (2026)

Vincristine Anaphylaxis and Rapid Drug Desensitisation
by: Béatrice Famin, et al.
Published: (2026)

Pain, Internalizing Symptoms, Posttraumatic Stress, and Alcohol Use Among Young Adult Survivors of Cancer
by: Kimberly L. Klages, et al.
Published: (2026)

Use of Oral Metformin Therapy for Therapy‐Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
by: Ankita Chakraborty, et al.
Published: (2026)

The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients
by: Michael Prodanuk, et al.
Published: (2024)

Posttraumatic Stress Symptoms in Children and Parents Shortly After Pediatric Brain Tumor Diagnosis: Prevalence and Risk Factors
by: Eva Kremer‐Hooft van Huijsduijnen, et al.
Published: (2025)

Reply to: Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
by: Jennifer Longoria, et al.
Published: (2024)

Therapy‐Associated Polyposis in Pediatric Cancer Survivors
by: Sue L. Jaspersen, et al.
Published: (2026)

The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease?
by: Charles T. Quinn, et al.
Published: (2024)

Tumor‐Specific Critical Intraoperative Findings Influence Multidisciplinary Therapy
by: Abdelhafeez Abdelhafeez, et al.
Published: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
by: Mikhail Lemeshev, et al.
Published: (2026)

Dermatofibrosarcoma Protuberans in Infancy: Targeted Therapy Facilitating Complete Resection
by: Aditi Tulsiyan, et al.
Published: (2026)

Proton Therapy for Locally Advanced Unresectable Ameloblastoma in a Child
by: Amanda Acevedo, et al.
Published: (2025)

Vaccine‐Mediated Immunity in Survivors of Childhood Cancer: A Scoping Review
by: Sophie Junak, et al.
Published: (2026)

Current Status and Challenges in Pediatric Radiation Therapy in China: A Nationwide Survey
by: JunFang Liao, et al.
Published: (2025)

Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma
by: Stephanie Fetzko, et al.
Published: (2024)

Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma”
Published: (2025)

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma
by: Subongkoch Subhadhirasakul, et al.
Published: (2026)

Higher Rates of Hypersensitivity Reactions to Calaspargase Compared With Pegaspargase: A Single Center Retrospective Review
by: Kyra McCarty, et al.
Published: (2025)

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study
by: Janka Kovács, et al.
Published: (2026)

Effect of Pelvic External Beam Radiation Therapy on Lower Urinary Tract Function of Pediatric Patients
by: Michael H. Edwards, et al.
Published: (2025)

Correction to “Effect of Pelvic Beam Radiation Therapy on Lower Urinary Tract Function of Pediatric Patients”
Published: (2026)

Coagulation Factor VII Deficiency: A Review of the Clinical Implications and Approaches to Replacement Therapy and Prophylaxis
by: Nader Cohan, et al.
Published: (2025)

Comment on: “Long‐Term Clinical Outcome and Quality of Life of Children, Adolescents, and Young Adults With Chordoma or Chondrosarcoma Treated With Pencil Beam Scanning Proton Therapy.” Commendable Progress in Pediatric Proton Therapy, but Methodological Precision Remains Crucial
by: Raza ur Rehman, et al.
Published: (2025)

What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High‐Dose Methotrexate Use in Pediatric Malignancies
by: Zachary L. Taylor, et al.
Published: (2025)

Access Program for Unapproved and Off‐Label Drug Use in Pediatric BRAF V600E‐Mutated Brain Tumors in Japan
by: Maya Suzuki, et al.
Published: (2025)

Pseudoprogression in Pediatric Spinal Pilocytic Astrocytoma and Myxopapillary Ependymoma after Proton Therapy: A Case Series
by: Kamaria L. Lee, et al.
Published: (2025)